Device Trial Radar · NCT02378883
Apollo™ Onyx™ Delivery Microcatheter Post Market Safety Study
Last checked: Nov 20, 2026Latest source record: Apr 29, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
112
Actual
Start
May 18, 2015
Primary completion
Feb 20, 2018
Study completion Feb 20, 2018
Sponsor
- Lead sponsor
- Medtronic Neurovascular Clinical AffairsPublic (MDT)
- Sponsor type
- Industry
- First posted
- Mar 4, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety of the Apollo™ Onyx™ Delivery Microcatheter used for delivery of the Onyx™ Liquid Embolic System during brain arteriovenous malformation (AVM) embolization procedures.
Conditions
- Arteriovenous Malformations
Interventions
Apollo™ Onyx™ Delivery Micro CatheterDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Catheter-related Adverse Events at 30 DaysTime frame: 30 days, after treatment with Onyx™ embolization using Apollo™ Onyx™ Delivery Microcatheter
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Radiology Imaging Associates, P.C.
Englewood, Colorado
Brigham's & Women Hospital
Boston, Massachusetts
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.